Page 19 - Functional impairment and cues for rehabilitation of head and neck cancer patients -
P. 19
REFERENCES
1. Integraal Kankercentrum Nederland. 2020 (http://www.cijfersoverkanker.nl/).
2. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol.
2011;29(32):4294-301.
3. Wyss A, Hashibe M, Chuang SC, et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International
Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol. 2013;178(5):679-90.
4. Lazarus C, Logemann JA, Pauloski BR, et al. Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients
with oral cancer. Head Neck. 2007;29(7):632-7.
5. Hutcheson KA, Lewin JS, Barringer DA, et al. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer.
2012;118(23):5793-9.
6. Mortensen HR, Jensen K, Aksglaede K, Behrens M, Grau C. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume
parameters. Radiother Oncol. 2013;107(3):288-94.
7. Wall LR, Ward EC, Cartmill B, Hill AJ. Physiological changes to the swallowing mechanism following (chemo)radiotherapy for head and neck
cancer: a systematic review. Dysphagia. 2013;28(4):481-93.
8. Grant S, Kamal M, Mohamed ASR, et al. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal
cancer survivors: Comparison of patient-reported outcome measures of swallowing. Cancer. 2019;125(10):1654-64.
9. Starmer HM, Tippett D, Webster K, et al. Swallowing outcomes in patients with oropharyngeal cancer undergoing organ-preservation treatment.
Head Neck. 2014;36(10):1392-7.
10. Hunter KU, Schipper M, Feng FY, et al. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-
reported, observer-rated, and objective outcomes. International journal of radiation oncology, biology, physics. 2013;85(4):935-40.
11. van der Molen L, Heemsbergen WD, de Jong R, et al. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiother Oncol.
2013;106(3):364-9.
12. Lindblom U, Garskog O, Kjellen E, et al. Radiation-induced trismus in the ARTSCAN head and neck trial. Acta oncologica (Stockholm, Sweden).
2014;53(5):620-7.
13. van der Geer SJ, Kamstra JI, Roodenburg JL, et al. Predictors for trismus in patients receiving radiotherapy. Acta oncologica (Stockholm, Sweden).
2016;55(11):1318-23.
14. van der Geer SJ, van Rijn PV, Kamstra JI, et al. Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study.
Head Neck. 2019;41(1):64-71.
15. Watters AL, Cope S, Keller MN, Padilla M, Enciso R. Prevalence of trismus in patients with head and neck cancer: A systematic review with meta-
analysis. Head Neck. 2019;41(9):3408-21.
16. Kraaijenga SA, Hamming-Vrieze O, Verheijen S, et al. Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after
chemoradiotherapy for advanced head and neck cancer. Head Neck. 2019;41(5):1387-94.
17. Van den Steen L, Van Gestel D, Vanderveken O, et al. Evolution of self-perceived swallowing function, tongue strength and swallow-related quality
of life during radiotherapy in head and neck cancer patients. Head Neck. 2019;41(7):2197-207.
18. de Almeida JR, Byrd JK, Wu R, et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic
review. Laryngoscope. 2014;124(9):2096-102.
19. Morisod B, Simon C. Meta-analysis on survival of patients treated with transoral surgery versus radiotherapy for early-stage squamous cell
carcinoma of the oropharynx. Head Neck. 2016;38 Suppl 1:E2143-50.
20. Evans M, Jones TM. Transoral Surgery or Radiotherapy for Oropharyngeal Carcinoma - Is It Either Or...? Clin Oncol (R Coll Radiol). 2016;28(7):413-
20.
21. Howard J, Masterson L, Dwivedi RC, et al. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary
oropharyngeal carcinoma. Cochrane Database Syst Rev. 2016;12:Cd010963.
22. Turner MT, Byrd JK, Ferris RL. Current Role of Surgery in the Management of Oropharyngeal Cancer. J Oncol Pract. 2016;12(11):1176-83.
23. Huang SH, Hahn E, Tsang RK, Chen ZJ, O’Sullivan B. The interplay of IMRT and transoral surgery in HPV-mediated oropharyngeal cancer: Getting
the balance right. Oral Oncol. 2018;86:171-80.
24. Sinha P, Karadaghy OA, Doering MM, et al. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical
treatment approach: A systematic review and meta-analysis. Oral Oncol. 2018;86:121-31.
25. Nichols AC, Theurer J, Prisman E, et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell
carcinoma (ORATOR): an open-label, phase 2, randomised trial. Lancet Oncol. 2019.
26. Nichols AC, Yoo J, Hammond JA, et al. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery
(ORATOR)--study protocol for a randomized phase II trial. BMC Cancer. 2013;13:133.
27. Maggiore RJ, Curran EK, Witt ME, et al. Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with
chemoradiation therapy. J Geriatr Oncol. 2013;4(4):327-33.
28. Shaw SM, Martino R. The normal swallow: muscular and neurophysiological control. Otolaryngologic clinics of North America. 2013;46(6):937-56.
29. Logemann JA. Evaluation and treatment of swallowing disorders. 2nd ed. Austin, Texas: Pro-ed; 1998.
1
Introduction
17
